News and Events

Enzymlogic is attending the seventh edition of the annual Spanish Drug Discovery Network Meeting. As in previous years, the objective of this conference is to discuss the latest achievements in Drug Discovery, Translational Research and Chemical Biology. The VII Spanish Drug Discovery Network Meeting will be held in Barcelona on November 12th and 13th, 2015….

A binding kinetics platform that guides the kinetic optimization of drug candidates and accelerates the drug discovery process. The Forum for the pharmaceutical, cosmetics and technology laboratories, FarmaForum, will be held in Madrid from 4-5 March, bringing together the entire Life Sciences and Pharmaceutical Industry, and making up a comprehensive showcase of new developments relating…

Transfiere, the first European Forum on Science, Technology and Innovation will bring together 450 companies, universities and technology centers. Enzymlogic will participate in the Transfiere Forum, the European Forum on Science, Technology and Innovation to be held for the fourth year in the Trade Fair and Congress Center of Malaga on February 11-12. This meeting…

Public and private funding; accelerator programs and crowdfunding. Biotech startups use the same sources of funding that any new business but the needs and expectations are more demanding. View the full article here.

Enzymlogic to be present at the next Spanish Drug Discovery Network Meeting to share ideas and explore new tools that will add real value to its customers’ drug discovery projects. The VI Spanish Drug Discovery Network Meeting will be held in Madrid on November 20th and 21st, 2014. This event aims to bring together an…

Medica, the world’s largest trade fair for medical technology & pharmaceutical industry, will open its gates from 12th to 15th November in Düsseldorf, Germany. Enzymlogic will be represented by the Science Park of Madrid at this event and will showcase its capabilities in binding kinetic and kinetic selectivity profiling. Medica represents the best way to…

The Enzymlogic’s platform allows pharmaceutical companies to develop drugs with higher clinical efficacy. View the full article here.

Enzymlogic provides binding kinetics expertise to a RETOS-COLABORACION project supported with €1.1 million funding from the Spanish Ministry of Economy and Competitiveness. Enzymlogic is joining a group of leading Spanish academic and industry researchers known as the DIGITAL (Diagnostic, monitoring and treatment of patients with genetic disorders detected through newborn screening and metabolic rare diseases)…

Enzymlogic is attending the 7th international meeting on biotechnology that will be held in Santiago the Compostela, Spain, on September 24th to 26th, 2014. We invite you to visit us at this event to learn what our services can do for your research. We will be glad to provide you with detailed information on how…